PEMBROLIZUMAB

Clinical trials for PEMBROLIZUMAB explained in plain language.

Never miss a new study

Get alerted when new PEMBROLIZUMAB trials appear

Sign up with your email to follow new studies for PEMBROLIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1 Terminated 1

New Triple-Threat treatment trial launches for tough ovarian cancer cases

Disease control Recruiting now

This study is testing whether combining three drugs—paclitaxel (or nab-paclitaxel), pembrolizumab, and mirabegron—can help control recurrent ovarian cancer. It aims to see if this combination shrinks tumors and is safe for patients. The trial will involve about 20 adults whose ca…

Matched conditions: PEMBROLIZUMAB

Phase: PHASE2 • Sponsor: Obstetrics & Gynecology Hospital of Fudan University • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

PEMBROLIZUMAB

Get alerted when new PEMBROLIZUMAB trials appear

New Triple-Threat treatment trial launches for tough ovarian cancer cases